BEXIMCO PHARMA.GDR REGS 1 (R2WA) — Financial Flexibility Index
BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Financial Flexibility Index of 0.61x as of June 2024. Free cash flow of €10.60 Billion (operating CF €8.36 Billion minus capex €2.23 Billion) represents 1% of total liabilities (€17.44 Billion). Check financial resilience of BEXIMCO PHARMA.GDR REGS 1 to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BEXIMCO PHARMA.GDR REGS 1 Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for BEXIMCO PHARMA.GDR REGS 1 across 3 annual periods. See working capital position of BEXIMCO PHARMA.GDR REGS 1 to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BEXIMCO PHARMA.GDR REGS 1 (2022–2024)
Year-by-year free cash flow to debt coverage for BEXIMCO PHARMA.GDR REGS 1. For the full company profile including market capitalisation, see BEXIMCO PHARMA.GDR REGS 1 (R2WA) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.61x | €10.60 Billion | €8.36 Billion | €17.44 Billion | ▲ +48.8% |
| 2023 | 0.41x | €8.79 Billion | €6.08 Billion | €21.54 Billion | ▲ +7.7% |
| 2022 | 0.38x | €8.15 Billion | €5.21 Billion | €21.51 Billion | — |